Right ventricular outflow tract obstruction risk factors: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(5 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
A recent review by the Mayo clinic does not support the role of SSRIs in the development of congenital heart disease including right ventricular outflow tract obstruction. <ref name="pmid19121250">{{cite journal| author=Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH, Watson WJ| title=Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. | journal=Mayo Clin Proc | year= 2009 | volume= 84 | issue= 1 | pages= 23-7 | pmid=19121250 | doi= | pmc=PMC2664566 | url= }} </ref>
The most common risk factor for the development of pulominic stenosis is the presence of a congenital bicuspid pulmonic valve. Risk factors that may speed up the progression of pulmonic stenosis include the same risk factors as [[atherosclerosis]]. <ref name="pmid4272665">{{cite journal| author=Roberts WC| title=Valvular, subvalvular and supravalvular aortic stenosis: morphologic features. | journal=Cardiovasc Clin | year= 1973 | volume= 5 | issue= 1 | pages= 97-126 | pmid=4272665 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4272665  }} </ref>
 
==Overview==
There are no established risk factors for [disease name].
 
OR
 
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
 
OR
 
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
 
OR
 
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
 
==Risk Factors==
There are no established risk factors for [disease name]. <ref name="pmid15956138">{{cite journal| author=Rajamannan NM, Nealis TB, Subramaniam M, Pandya S, Stock SR, Ignatiev CI et al.| title=Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. | journal=Circulation | year= 2005 | volume= 111 | issue= 24 | pages= 3296-301 | pmid=15956138 | doi=10.1161/CIRCULATIONAHA.104.473165 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15956138  }} </ref>
 
OR
 
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
 
OR
 
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
===Common Risk Factors===
*Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral. <ref name="pmid7743689">{{cite journal |vauthors=Waller BF, Howard J, Fess S |title=Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part II |journal=Clin Cardiol |volume=18 |issue=3 |pages=167–74 |date=March 1995 |pmid=7743689 |doi=10.1002/clc.4960180312 |url=}}</ref>
*Common risk factors in the development of [disease name] include:
**[Risk factor 1]
**[Risk factor 2]
**[Risk factor 3]
 
===Less Common Risk Factors===
*Less common risk factors in the development of [disease name] include:
**[Risk factor 1]
**[Risk factor 2]
**[Risk factor 3]


==References==
==References==
{{reflist|2}}
{{Reflist|2}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Disease]]
{{WH}}
[[Category:Cardiology]]
{{WS}}
[[Category:Congenital heart disease]]
[[Category: (name of the system)]
[[Category:Pediatrics]]

Latest revision as of 15:25, 24 February 2020

Right ventricular outflow tract obstruction Microchapters

Home

Patient Information

Overview

Anatomy of Pulmonary Valve

Classification

Pulmonary valve stenosis
Pulmonary subvalvular stenosis
Pulmonary supravalvular stenosis
Pulmonary atresia

Pathophysiology

Causes

Differentiating Right ventricular outflow tract obstruction from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

Echocardiography

Cardiac Catheterization

Pulmonary Angiography

Treatment

Indications For Surgery

Surgery

Pre-Operative A/P

Post-Operative A/P

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pulmonary artery conduits/Prosthetic Valves

Double-Chambered Right Ventricle

Case Studies

Case #1

Right ventricular outflow tract obstruction risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Right ventricular outflow tract obstruction risk factors

CDC on Right ventricular outflow tract obstruction risk factors

Right ventricular outflow tract obstruction risk factors in the news

Blogs on Right ventricular outflow tract obstruction risk factors

Directions to Hospitals Treating Right ventricular outflow tract obstruction risk factors

Risk calculators and risk factors for Right ventricular outflow tract obstruction risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The most common risk factor for the development of pulominic stenosis is the presence of a congenital bicuspid pulmonic valve. Risk factors that may speed up the progression of pulmonic stenosis include the same risk factors as atherosclerosis. [1]

Overview

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Risk Factors

There are no established risk factors for [disease name]. [2]

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Common Risk Factors

  • Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral. [3]
  • Common risk factors in the development of [disease name] include:
    • [Risk factor 1]
    • [Risk factor 2]
    • [Risk factor 3]

Less Common Risk Factors

  • Less common risk factors in the development of [disease name] include:
    • [Risk factor 1]
    • [Risk factor 2]
    • [Risk factor 3]

References

  1. ↑ Roberts WC (1973). "Valvular, subvalvular and supravalvular aortic stenosis: morphologic features". Cardiovasc Clin. 5 (1): 97–126. PMID 4272665.
  2. ↑ Rajamannan NM, Nealis TB, Subramaniam M, Pandya S, Stock SR, Ignatiev CI; et al. (2005). "Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation". Circulation. 111 (24): 3296–301. doi:10.1161/CIRCULATIONAHA.104.473165. PMID 15956138.
  3. ↑ Waller BF, Howard J, Fess S (March 1995). "Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part II". Clin Cardiol. 18 (3): 167–74. doi:10.1002/clc.4960180312. PMID 7743689.

Template:WH Template:WS [[Category: (name of the system)]

Retrieved from "https://www.wikidoc.org/index.php?title=Right_ventricular_outflow_tract_obstruction_risk_factors&oldid=1600101"